My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.410 -0.090 (-6.00%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inhibikase Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

24 Stocks Moving in Wednday's Pre-Market Session ↗

June 16, 2021

Gainers Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) rose 43.6% to $2.93 in pre-market trading after a 13G filing from Ra Capital showed a 7.5% stake in the company. Greenland...

Via Benzinga

Inhibikase Therapeutics Stock Drops After Follow-On Equity Offering Of $45M Issued At 26% Discount ↗

June 16, 2021

Inhibikase Therapeutics Inc (NASDAQ: IKT) has priced an underwritten public offering of 15 million shares at $3/share for gross proceeds of approximately $45...

Via Benzinga

44 Biggest Movers From Yesterday ↗

June 16, 2021

Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share. Alfi, Inc. (NASDAQ: ALF) shares...

Via Benzinga

Topics Initial Public Offering

Mid-Afternoon Market Update: Dow Tumbles 250 Points; Enochian Biosciences Shares Spike Higher ↗

June 14, 2021

Toward the end of trading Monday, the Dow traded down 0.74% to 34,225.89 while the NASDAQ rose 0.45% to 14,132.55. The S&P also fell, dropping 0.27% to 4,236.03. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Day Market Update: Nasdaq Rises Over 50 Points; Washington Prime Group Shares Plunge ↗

June 14, 2021

Midway through trading Monday, the Dow traded down 0.65% to 34,255.66 while the NASDAQ rose 0.41% to 14,126.79. The S&P also fell, dropping 0.23% to 4,237.53. The U.S. has the...

Via Benzinga

Topics Stocks

60 Biggest Movers From Yesterday ↗

June 15, 2021

Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

June 14, 2021

Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request...

Via Benzinga

NASDAQ Co. Working Towards Advanced Treatments for Parkinson’s Disease and Cancer. Inhibikase Therapeutics (NASDAQ: IKT)

June 07, 2021

NASDAQ Company Diligently Working Towards Advanced Treatments for Parkinson’s Disease and Cancer: Inhibikase Therapeutics, Inc. (Stock Symbol: IKT)

Via EIN Presswire

Topics Intellectual Property

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗

May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks ↗

May 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

44 Biggest Movers From Yesterday ↗

April 23, 2021

Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares...

Via Benzinga

Topics Initial Public Offering

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗

May 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex ↗

April 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...

Via Benzinga

20 Stocks Moving in Wednesday's Pre-Market Session ↗

April 07, 2021

Gainers UTime Limited (NASDAQ: UTME) rose 39.7% to $54.50 in pre-market trading. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share. SOS...

Via Benzinga

Topics Initial Public Offering

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.